The rally of Indian equities reached a new high today(24th November 2020) when the Nifty50 index surpassed the 13,000-mark for the first time ever. The S&P BSE Sensex, meanwhile, kissed the 44,500-mark in intra-day deals.
A cocktail of better-than-expected earnings, improved Goods and Services Tax (GST) collection, better macro-data, and progress in Covid-19 vaccine development have pushed the markets to their peaks, analysts say. That said, while the markets look poised for a sustained uptrend, investors may consider profit-booking gradually, according to some analysts.
Four virus-vaccines – one each by Pfizer and BioNTech; AstraZeneca and Oxford; Sputnik V; and Moderna Inc – have shown over 90 percent efficacy. The development, analysts say, will trigger rallies in the beaten-down and cyclical stocks, while starting the cycle of economic recovery.
Read more